vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Celsius Holdings, Inc. (CELH). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $721.6M, roughly 1.1× Celsius Holdings, Inc.). Celsius Holdings, Inc. runs the higher net margin — 3.4% vs 0.5%, a 2.9% gap on every dollar of revenue. On growth, Celsius Holdings, Inc. posted the faster year-over-year revenue change (117.2% vs 7.5%). Over the past eight quarters, Celsius Holdings, Inc.'s revenue compounded faster (42.4% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Celsius Holdings, Inc. is an American company that produces a range of fitness and energy drinks under the brand name Celsius. The company's products are marketed as healthy, to which the CEO attributes the brand's success.
ACHC vs CELH — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $721.6M |
| Net Profit | $4.5M | $24.7M |
| Gross Margin | — | 47.4% |
| Operating Margin | — | 3.6% |
| Net Margin | 0.5% | 3.4% |
| Revenue YoY | 7.5% | 117.2% |
| Net Profit YoY | -50.8% | 231.1% |
| EPS (diluted) | $0.05 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $721.6M | ||
| Q3 25 | $851.6M | $725.1M | ||
| Q2 25 | $869.2M | $739.3M | ||
| Q1 25 | $770.5M | $329.3M | ||
| Q4 24 | $774.2M | $332.2M | ||
| Q3 24 | $815.6M | $265.7M | ||
| Q2 24 | $796.0M | $402.0M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $24.7M | ||
| Q3 25 | $36.2M | $-61.0M | ||
| Q2 25 | $30.1M | $99.9M | ||
| Q1 25 | $8.4M | $44.4M | ||
| Q4 24 | $32.6M | $-18.9M | ||
| Q3 24 | $68.1M | $6.4M | ||
| Q2 24 | $78.5M | $79.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 47.4% | ||
| Q3 25 | — | 51.3% | ||
| Q2 25 | — | 51.5% | ||
| Q1 25 | — | 52.3% | ||
| Q4 24 | — | 50.2% | ||
| Q3 24 | — | 46.0% | ||
| Q2 24 | — | 52.0% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 3.6% | ||
| Q3 25 | 4.7% | -11.0% | ||
| Q2 25 | 5.8% | 19.3% | ||
| Q1 25 | 1.7% | 15.8% | ||
| Q4 24 | 4.9% | -5.6% | ||
| Q3 24 | 12.1% | -1.2% | ||
| Q2 24 | 13.4% | 23.4% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 3.4% | ||
| Q3 25 | 4.3% | -8.4% | ||
| Q2 25 | 3.5% | 13.5% | ||
| Q1 25 | 1.1% | 13.5% | ||
| Q4 24 | 4.2% | -5.7% | ||
| Q3 24 | 8.4% | 2.4% | ||
| Q2 24 | 9.9% | 19.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.04 | ||
| Q3 25 | $0.40 | $-0.27 | ||
| Q2 25 | $0.33 | $0.33 | ||
| Q1 25 | $0.09 | $0.15 | ||
| Q4 24 | $0.36 | $-0.10 | ||
| Q3 24 | $0.74 | $0.00 | ||
| Q2 24 | $0.85 | $0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $398.9M |
| Total DebtLower is stronger | $2.5B | $676.9M |
| Stockholders' EquityBook value | $2.0B | $1.2B |
| Total Assets | $5.5B | $5.1B |
| Debt / EquityLower = less leverage | 1.29× | 0.57× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $398.9M | ||
| Q3 25 | $118.7M | $806.0M | ||
| Q2 25 | $131.4M | $615.2M | ||
| Q1 25 | $91.2M | $977.3M | ||
| Q4 24 | $76.3M | $890.2M | ||
| Q3 24 | $82.1M | $903.7M | ||
| Q2 24 | $77.2M | $903.2M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $676.9M | ||
| Q3 25 | $2.3B | $870.5M | ||
| Q2 25 | $2.3B | $871.9M | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $1.2B | ||
| Q3 25 | $3.1B | $1.2B | ||
| Q2 25 | $3.1B | $1.3B | ||
| Q1 25 | $3.0B | $443.1M | ||
| Q4 24 | $3.1B | $399.9M | ||
| Q3 24 | $3.0B | $423.6M | ||
| Q2 24 | $3.0B | $415.8M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $5.1B | ||
| Q3 25 | $6.4B | $5.3B | ||
| Q2 25 | $6.3B | $3.8B | ||
| Q1 25 | $6.1B | $1.9B | ||
| Q4 24 | $6.0B | $1.8B | ||
| Q3 24 | $5.9B | $1.7B | ||
| Q2 24 | $5.7B | $1.7B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.57× | ||
| Q3 25 | 0.74× | 0.72× | ||
| Q2 25 | 0.74× | 0.69× | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $-119.4M |
| Free Cash FlowOCF − Capex | — | $-130.0M |
| FCF MarginFCF / Revenue | — | -18.0% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | 13.78× | -4.83× |
| TTM Free Cash FlowTrailing 4 quarters | — | $323.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $-119.4M | ||
| Q3 25 | $73.2M | $331.8M | ||
| Q2 25 | $133.5M | $43.7M | ||
| Q1 25 | $11.5M | $103.4M | ||
| Q4 24 | $116.7M | $75.7M | ||
| Q3 24 | $163.1M | $12.9M | ||
| Q2 24 | $171.1M | $39.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $-130.0M | ||
| Q3 25 | $-63.0M | $321.5M | ||
| Q2 25 | $-34.2M | $35.5M | ||
| Q1 25 | $-163.2M | $96.4M | ||
| Q4 24 | $-86.8M | $70.3M | ||
| Q3 24 | $-27.1M | $8.7M | ||
| Q2 24 | $16.9M | $30.4M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | -18.0% | ||
| Q3 25 | -7.4% | 44.3% | ||
| Q2 25 | -3.9% | 4.8% | ||
| Q1 25 | -21.2% | 29.3% | ||
| Q4 24 | -11.2% | 21.2% | ||
| Q3 24 | -3.3% | 3.3% | ||
| Q2 24 | 2.1% | 7.6% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 1.5% | ||
| Q3 25 | 16.0% | 1.4% | ||
| Q2 25 | 19.3% | 1.1% | ||
| Q1 25 | 22.7% | 2.1% | ||
| Q4 24 | 26.3% | 1.6% | ||
| Q3 24 | 23.3% | 1.6% | ||
| Q2 24 | 19.4% | 2.3% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | -4.83× | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | 0.44× | ||
| Q1 25 | 1.37× | 2.33× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 2.03× | ||
| Q2 24 | 2.18× | 0.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
CELH
Segment breakdown not available.
